Page 5 - News Ratings For Marinus Pharmaceuticals Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from News ratings for marinus pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In News Ratings For Marinus Pharmaceuticals Daily Today - Breaking & Trending Today

Marinus Pharmaceuticals (NASDAQ:MRNS) Cut to Sell at StockNews.com

StockNews.com lowered shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) from a hold rating to a sell rating in a research note released on Wednesday morning. MRNS has been the subject of several other reports. Truist Financial reduced their target price on shares of Marinus Pharmaceuticals from $32.00 to $25.00 and set a buy rating […] ....

Nova Scotia , Lion Point , Northwest Territories , Institutional Trading Of Marinus Pharmaceuticals , Marinus Pharmaceuticals Stock , Marinus Pharmaceuticals , Analyst Recommendations For Marinus Pharmaceuticals , Marinus Pharmaceuticals Inc , Blackrock Inc , Eventide Asset Management , Royal Bank , Franklin Resources Inc , News Ratings For Marinus Pharmaceuticals Daily , Free Report , Moderate Buy , Get Free Report , Asset Management , Point Capital , Marinus Pharmaceuticals Daily ,

Marinus Pharmaceuticals (NASDAQ:MRNS) Shares Down 7.4%

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) dropped 7.4% on Tuesday . The stock traded as low as $9.20 and last traded at $9.22. Approximately 137,536 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 372,639 shares. The stock had previously closed at $9.96. Wall Street Analyst […] ....

United States , Marinus Pharmaceuticals Inc , Financial Group , Jennison Associates , News Ratings For Marinus Pharmaceuticals Daily , Harvest Investment Services , Marinus Pharmaceuticals , York Mellon Corp , Marinus Pharmaceuticals Stock Down , American International Group Inc , Get Free Report , Truist Financial , Pharmaceuticals Stock Down , International Group , New York Mellon Corp , Marinus Pharmaceuticals Daily , Nasdaq Mrns ,

Analysts Set Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Target Price at $20.44

Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) have earned an average rating of “Moderate Buy” from the eight brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month target price […] ....

Marinus Pharmaceuticals Inc , Charles Schwab Investment Management Inc , Goldman Sachs Group Inc , Hedge Funds Weigh In On Marinus Pharmaceuticals , Marinus Pharmaceuticals , Analyst Recommendations For Marinus Pharmaceuticals , Marinus Pharmaceuticals Stock Down , Marinus Pharmaceuticals Company Profile , News Ratings For Marinus Pharmaceuticals Daily , Metlife Investment Management , Renaissance Technologies , Get Free Report , Life Investment Management , Schwab Investment Management , Sachs Group , Quantbot Technologies , Pharmaceuticals Stock Down , Get Free , Marinus Pharmaceuticals Daily , Nasdaq Mrns ,

Marinus Pharmaceuticals (NASDAQ:MRNS) Trading Down 7.4%

Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) dropped 7.4% during trading on Tuesday . The company traded as low as $9.20 and last traded at $9.22. Approximately 137,536 shares were traded during mid-day trading, a decline of 63% from the average daily volume of 372,639 shares. The stock had previously closed at […] ....

Bluepath Capital Management , Marinus Pharmaceuticals Inc , Institutional Trading Of Marinus Pharmaceuticals , Marinus Pharmaceuticals Stock Down , Life Insurance Co , Ameritas Investment Partners Inc , News Ratings For Marinus Pharmaceuticals Daily , Marinus Pharmaceuticals Company Profile , Marinus Pharmaceuticals , Get Free Report , Pharmaceuticals Stock Down , Path Capital Management , Ameritas Investment Partners , Marinus Pharmaceuticals Daily , Nasdaq Mrns ,

Marinus Pharmaceuticals (NASDAQ:MRNS) Shares Down 7.4%

Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) were down 7.4% during mid-day trading on Tuesday . The company traded as low as $9.20 and last traded at $9.22. Approximately 137,536 shares traded hands during trading, a decline of 63% from the average daily volume of 372,639 shares. The stock had previously closed […] ....

Blackrock Inc , Marinus Pharmaceuticals Company Profile , News Ratings For Marinus Pharmaceuticals Daily , Marinus Pharmaceuticals , Marinus Pharmaceuticals Trading Down , Marinus Pharmaceuticals Inc , Institutional Trading Of Marinus Pharmaceuticals , Franklin Resources Inc , Eventide Asset Management , Get Free Report , Truist Financial , Pharmaceuticals Trading Down , Asset Management , Point Capital , Marinus Pharmaceuticals Daily , Nasdaq Mrns ,